Kell BioTech is modernising how blood banks across India operate — from donor registration to national compliance reporting. Here's an overview for prospective investors and partners.
Healthcare Technology — Blood Bank Management Software & Equipment
India and international markets across Asia, the Middle East, and Africa
Blood Bank Management Software, Automation, and Blood Bank Equipment
Blood banks, hospitals, and diagnostic laboratories
Active blood banks running Kell BioTech.
Donors safely managed till date.
Successful blood issues processed.
Healthcare workers on the platform.
India's blood banking infrastructure is undergoing a digital shift — driven by national reporting requirements like eRaktKosh, the Ayushman Bharat Digital Mission (ABHA), and NABH/NACO compliance expectations. Most blood banks still run on paper registers and spreadsheets, creating a large addressable market for purpose-built software.
Kell BioTech combines software, hardware integration, and category-specific domain knowledge — covering donor management, inventory, crossmatch safety, and compliance reporting — in a single platform built specifically for this market, rather than adapted from generic hospital software. Read more on our About page and product overview.
Share your details and our team will follow up.
What does Kell BioTech do?
Kell BioTech builds Blood Bank Management Software, blood bank automation, and blood bank equipment for hospitals, blood banks, and diagnostic laboratories, primarily across India with a growing international footprint.
How can I learn more before investing or partnering?
Submit the investor inquiry form on this page with your details, and our team will reach out to schedule a call and share more information about the business.
Does Kell BioTech work with international markets?
Yes, alongside its core Indian market, Kell BioTech serves customers across Asia, the Middle East, and Africa.